Diurnal Salivary Cortisol and Regression Status in MECP2 Duplication Syndrome

Abstract

MECP2 duplication syndrome is an X-linked genomic disorder that is characterized by infantile hypotonia, intellectual disability, and recurrent respiratory infections. Regression affects a subset of individuals, and the etiology of regression has yet to be examined. In this study, alterations in the hypothalamus-pituitary-adrenal axis, including diurnal patterns in salivary cortisol, were examined in 4 males with MECP2 duplication syndrome who had regression and 4 males with the same syndrome without regression (aged 3-22 years). Individuals who had experienced regression do not exhibit typical diurnal cortisol rhythms, and their profiles were flatter through the day. In contrast, individuals with MECP2 duplication syndrome who had not experienced regression showed more typical patterns of higher cortisol levels in the morning with linear decreases throughout the day. This study is the first to suggest a link between atypical diurnal cortisol rhythms and regression status in MECP2 duplication syndrome and may have implications for treatment.

Keywords

cortisol regression

Get full access to this article

View all access options for this article.

References

Ramocki

Peters

Tavyev

. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol. 2009;66:771–782.

Van Esch

. MECP2 duplication syndrome. Mol Syndromol. 2012;2:128–136.

Friez

Jones

Clarkson

. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics. 2006;118:e1687–e1695.

Amir

Van den Veyver

Wan

Tran

Francke

Zoghbi

. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188.

Peters

Hundley

Wilson

Carvalho

Lupski

Ramocki

. Brief report: regression timing and associated features in MECP2 duplication syndrome. J Autism Dev Disord. 2013;43:2484–2490.

Cobb

Fei

Jonsson

. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren’s syndrome. Ann Rheum Dis. 2010;69:1731–1732.

Sawalha

Webb

Han

. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One. 2008;3:e1727.

Baizabal-Carvallo

Bonnet

Jankovic

. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm. 2013;120:1579–1589.

Baizabal-Carvallo

Jankovic

. Movement disorders in autoimmune diseases. Mov Disord. 2012;27:935–946.

10.

Tzioufas

Tsonis

Moutsopoulos

. Neuroendocrine dysfunction in Sjogren’s syndrome. Neuroimmunomodulation. 2008;15:37–45.

11.

Straub

Buttgereit

Cutolo

. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases—a role for misguided energy regulation. Clin Exp Rheumatol. 2011;29(5 suppl 68):S23–S31.

12.

DeSantis

DiezRoux

Hajat

. Associations of salivary cortisol levels with inflammatory markers: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology. 2012;37:1009–1018.

13.

Samaco

Mandel-Brehm

McGraw

Shaw

McGill

Zoghbi

. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat Genet. 2012;44:206–211.

14.

Dantzer

Kelley

. Twenty years of research on cytokine-induced sickness behavior. Brain Beh Immun. 2007;21:153–160.

15.

Fyffe

Neul

Samaco

. Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron. 2008;59:947–958.

16.

van der Goes

Bossema

Hartkamp

. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren’s syndrome. J Rheumatol. 2011;38:285–288.

17.

Pool

Whipp

Skasick

Alavi

Bland

Axford

. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology. 2004;43:43–48.

18.

Roozendaal

Kim

Wolf

Kim

Sung

Lee

. The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood. Psychoneuroendocrinology. 2012;37:20–26.

19.

Melief

de Wit

van Eden

. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Acta Neuropathol. 2013;126:237–249.

20.

Schroeder

Wichers

Klingmuller

. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone. Crit Care Med. 2001;29:310–316.

21.

Parr

Le Couteur

Baird

. Early developmental regression in autism spectrum disorder: evidence from an international multiplex sample. J Autism Dev Disord. 2011;41:332–340.

22.

Luyster

Richler

Risi

. Early regression in social communication in autism spectrum disorders: a CPEA Study. Dev Neuropsychol. 2005;27:311–336.

23.

Gunnar

White

. Salivary cortisol measures in infant and child assessment. In: Singer

Zeskind

, eds. Biobehavioral assessment of the infant. New York: Guilford Press; 2001:167–189.